| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.039 | 0.5 |